JB Chemicals & Pharmaceuticals acquires Razel franchise from Glenmark

22 Dec 2022 Evaluate

JB Chemicals & Pharmaceuticals has completed acquisition of ‘Razel’ franchise from Glenmark Pharmaceuticals. Earlier, the company had entered into an agreement with Glenmark Pharmaceuticals to acquire the Razel (Rousvastatin) franchise for the India and Nepal region.

The company sees growth potential from the acquired portfolio as it is synergistic with its cardiac segment and will help it leverage its Go to Market Model. Further the products provide good operating leverage and are margin accretive, given its attractive margin profile. The cost of acquisition is Rs 313.7 crore (excluding working capital and taxes).

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1901.55 7.35 (0.39%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×